(FILES) A photograph shows Sanofi logo on Sanofi's building at a French pharmaceutical company Sanofi's laboratory in Val-de-Reuil, north-eastern France, on September 5, 2022. The government is requesting an "exhaustive assessment" of the public aid that the pharmaceutical group Sanofi has received over the last ten years, announced on October 15, 2024 the Minister of the Economy Antoine Armand, confirming the "possible presence of the State on the board of directors" of Opella, which markets Doliprane. (Photo by Lou BENOIST / AFP) (Photo by LOU BENOIST/AFP via Getty Images)